Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction]
Hinz M, Stein A, Cole T. Drug Healthc Patient Saf. 2014;6:93— 99. The Editor-in-chief and Publisher of Drug, Healthcare and Patient Safety wish to retract the published article. Following the conclusion of our investigation the decision has been made to retract...
Main Authors: | Hinz M, Stein A, Cole T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | Drug, Healthcare and Patient Safety |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-management-of-l-dopa-overdose-in-the-competitive-inhib-peer-reviewed-article-DHPS |
Similar Items
-
Management of L-Dopa Overdose in the Competitive Inhibition State [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01) -
The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
by: Galit Fichman, et al.
Published: (2014-08-01) -
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
by: Hinz M, et al.
Published: (2021-03-01) -
Personalizing functional Magnetic Resonance Protocols for Studying Neural Substrates of Motor Deficits in Parkinson’s Disease
by: Holiga, Štefan
Published: (2013) -
Amino Acid Management of Parkinson’s Disease: a Case Study [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)